Loading clinical trials...
Loading clinical trials...
Primary objective The objective of this study is to compare anti-Xa levels obtained with a standard high dose thrombosis prophylaxis in COVID-19 intensive care-patients compared with anti-Xa levels ob...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rijnstate Hospital
NCT07350499 · Arterial Thromboembolism, Venous Thromboembolism, and more
NCT07213778 · Symptomatic Venous Thromboembolism (VTE)
NCT07303816 · Venous Thromboembolism, Cancer, and more
NCT05993390 · Neuromuscular Blockade, Critical Illness, and more
NCT05218083 · COVID-19, Critical Illness, and more
Monique de Maat
Arnhem
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions